Evaluation of clinical efficacy of a combined analgetic drug "Fanigan" for symptomatic treatment of patients with pain syndrome of various genesis
Journal: Medicni perspektivi (Vol.22, No. 1)Publication Date: 2017-04-04
Authors : Mamchur V.Y.; Nosivets D.S.; Nalotov S.V.; Palamarchuk V.I.; Guryanov V.G.; Ogol A.J.;
Page : 89-96
Keywords : pain syndrome; NSAID; clinical efficacy; Fanigan;
Abstract
The authors studied the efficacy of combined drug Fanigan (paracetamol 500 mg and diclofenac sodium 50 mg) (production of "Kusum Pharm" (Ukraine) or "Kusum Heltker PVT. LTD" (India) in tablets for symptomatic treatment of patients with pain syndrome. A pronounced clinical efficiency of its application in patients with pain syndrome of various genesis in a daily dose from 2 to 3 tablets for 3 to 7 days was established. The obtained data on the clinical efficacy of the drug. Fanigan in the treatment of patients with pain syndrome of various genesis allow to recommend it for application in wide clinical practice.
Other Latest Articles
- Clinical-anamnestic features and quality of life in women with endometrial pathology on the background of uterine myoma
- Muscle dysfunction in tension-type headache in adolescents and methods of its correction
- Features of the mental status of patients with community-acquired pneumonia, combined with a chronic pathology of the hepatobiliary system of non-viral genesis
- Histomorphological features of combined forms of tuberculosis and lung cancer
- Dynamics of parameters of ultrasonic, microbiological and cytological investigations in the treatment of postoperative wound complications using magnesium containing minerals in the elderly patients
Last modified: 2017-05-13 19:35:12